GeoSolar Technologies Inc. Set to Benefit from the DOE’s Investments in Geothermal Energy

 

• The Department of Energy recently agreed on a $74 million funding initiative aimed at 7 pilot projects exploring different methods of harnessing geothermal energy
• Geothermal energy currently generates 3.7 billion kilowatts per annum of electricity in the United States – enough to power 2.5 million homes
• GeoSolar Technologies has been an early mover within the geothermal technology space, using the renewable energy source as the foundation of its revolutionary SmartGreen(TM) Home system

Around 2,900 kilometers (1,800 miles) beneath the Earth’s surface lies the hottest part of our planet – the core. A small portion of the core’s heat, which can rise to over 5,000 degrees Celsius or 9,000 degrees Fahrenheit, is delivered from the friction and gravitational pull which results from the Earth’s creation over 4 billion years ago; however, most of the Earth’s heat is generated through the constant decay of radioactive isotopes, namely postassium-40 and thorium-232. Harnessing the heat generated by the Earth’s core, a process called geothermal energy, is still in its relative infancy; in the United States today, geothermal energy currently generates about 3.7 billion kilowatt hours of electricity per year – enough to power over 2.5 million homes. However, that pales in comparison to more conventional fossil fuels; coal alone accounted for 898 billion kilowatt hours of electricity in the U.S. as of 2021 (https://ibn.fm/Ues2C). That figure may now be poised to change.

In early February 2023, the U.S. Department of Energy (“DOE”) announced a funding opportunity of up to $74 million for seven pilot projects which would individually seek to test the efficacy and scalability of enhanced geothermal systems (“EGS”). Forming part of the landmark Bipartisan Infrastructure Law (“BIL”), the pilot projects to use innovative technology and a variety of development techniques to capture the Earth’s abundant heat sources in diverse geologic settings. Moreover, and through this investment, the DOE hopes that research from the findings will prove a justifiable case for the potential for geothermal energy to provide reliable, around-the-clock electricity to tens of millions of homes across the country (https://ibn.fm/rx1SW).

What is unique about geothermal energy, is the basis by which it forms. Recent findings from the University of California Berkeley discovered that the Earth’s core may contain as much as 1,200 parts per million of potassium-40, or just over one tenth of one percent of the core’s entire mass.

“This amount may seem small and is comparable to the concentration of radioactive potassium naturally present in bananas. Combined over the entire mass of the Earth’s core, however, it can be enough to provide one-fifth of the heat given off by the Earth,” stated Kanani Lee, a Ph.D. researcher at UC Berkeley (https://ibn.fm/MyO5M).

As potassium-40 decays, its nucleus changes, emitting enormous amounts of energy and radiation. Heat from the Earth’s core radiates outwards, warming rocks, water, gas and other geological material on the way; studies have shown that the heat dissipated in temperature by approximately 25 Celsius per 1 kilometer of depth (1 degree Fahrenheit per 77 feet). Whilst in some areas of the world such as Iceland, abundant sources of hot, easily accessible underground reservoirs of water make it possible to rely on geothermal sources as a safe, dependable, and inexpensive source of energy, the process to harness geothermal energy in the United States is somewhat different (https://ibn.fm/neDZT).

GeoSolar Technologies (“GST”), a Colorado-based climate technology Company pioneering an approach into clean energy solutions for households, has been an early mover within geothermal energy in the United States. Through the introduction of its proprietary SmartGreen(TM) Home system – an environmentally friendly, renewable energy focused technology designed to harness energy from the Earth and sun to power and purify homes and automobiles without the use of fossil fuels, GeoSolar have looked to tackle the astounding thirty percent of global greenhouse gases generated by households every year.

The heart of the SmartGreen(TM) Home system lays within geothermal ground-based energy beneath the average home. Through a truck-mounted or modular sonic rig, GeoSolar seeks to drill 4–6-inch wells down 300-400 feet below the surface, subsequently inserting high-density polyethylene pipe ground loops that can tap into the unlimited source of geothermal energy available. The ground loops operate the geothermal system function by constantly circulating non-toxic fluid to a high-volume heat/air pump. The heat pump and circulating fluid continuously transfers heat from the home into or out of the ground depending on the season. Moreover, the system can be easily connected to existing air ducts or radiant flooring loops, thereby accounting for all of the home’s heating, cooling and hot water requirements.

Historically, the key barriers towards greater geothermal energy adoption lays within the financial sphere. Geothermal power plant suffers from much higher capital costs (and therefore, slower payback periods) relative to other forms of renewable energy. Moreover, existing techniques for placing wells at traditional hydrothermal sites have been largely unsuccessful, with many wells failing to produce enough to go into use – variables which have detrimentally affected incremental investment within the technology. As a result, the largest geothermal steam electricity plant in the United States, located in California, was built as far back as September 1960 (https://ibn.fm/0KQFz). With its most recent funding endeavors, the DOE hopes to change this paradigm. GeoSolar Technologies for one, stand to benefit from the ongoing shift in the United States’ renewable energy mix.

For more information, visit the company’s website at www.GeoSolarPlus.com.

NOTE TO INVESTORS: The latest news and updates relating to GeoSolar Technologies are available in the company’s newsroom at https://ibn.fm/GST

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Utopia VR Disrupting Future of Enterprise, Education and Corporate Remote Offerings with Distinct Metaverse Solution

 Utopia VR is a diversified technology company, pioneering the concept of the “Metaverse-as-a-Service,” while centering its focus on the provision of virtual spaces for both businesses and consumer audiences. “Launched in April 2022, Utopia VR’s metaverse solution has emerged as the world’s first web-based, mobile-friendly, audio and video conferencing platform utilizing innovative 3D web technology. Users on the platform are enabled to hold Zoom-like virtual meetings in 3D or experience those same meetings in lifelike virtual reality. Moreover, and uniquely amongst peers, Utopia VR’s metaverse operates across all devices – PC, mobile and virtual reality headsets – whereas many competitors only work on VR or PC,” a recent article reads. “Utopia VR’s strategy is clear. The company has sought to revolutionize the workplace as we know it, focusing its business model on disrupting the future of enterprise, education and corporate remote solutions. With a management team boasting extensive experience within both technology and financial markets, an innovative and live product platform, and having started generating revenues, Utopia VR looks well placed to capitalize and pioneer the implementation of the metaverse in the workplace.”

To view the full article, visit https://ibn.fm/6S1Yn

About Utopia VR

Utopia VR, headquartered in Kelowna, British Columbia, is one of the world’s first “Metaverse-as-a-Service” solutions for business. The company’s hosted and managed subscription software provides businesses a device-agnostic platform for the management of private 3D metaverse meeting spaces. Users can host and attend Zoom-like virtual meetings in lifelike virtual reality – with no software downloads – engaging their audiences in a more collaborative and fun way. For more information, visit the company’s website at www.UtopiaVR.com.

NOTE TO INVESTORS: The latest news and updates relating to Utopia VR are available in the company’s newsroom at https://ibn.fm/Utopia

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) and Its Collaborators Are Positioned to Rapidly Develop COVID-19 Treatments to Neutralize Emerging Variants

 

• BiondVax is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products
• The company primarily targets infectious diseases and autoimmune diseases, with its lead candidate, an inhaled COVID-19 NanoAb therapy, the subject of preclinical studies
• So far, the preclinical studies have shown that the NanoAb results in significantly milder illness and faster recovery, eliminates the SARS-CoV-2 virus from the lungs, and prevents illness when administered prophylactically
• The FDA has revoked the authorization of multiple mAb treatments and one mAb prophylactic drug, creating a significant gap in a market that has shown strong demand for COVID-19 treatments
• BiondVax is uniquely positioned to meet this demand, backed by an extensive library of NanoAbs that allows it to rapidly develop neutralizing treatment as soon as a new variant emerges

The Food and Drug Administration (“FDA”) has, over the last two years, authorized several drugs as treatments for mild-to-moderate COVID-19 or as pre-exposure prophylaxis (“PrEP”) for the prevention of the disease. Most of these drugs were based on human monoclonal antibody (“mAb”) technology and were designed to boost the immune system by mimicking natural neutralizing antibodies. The mAbs would bind with the SARS-CoV-2 virus’ receptor binding domain, a section of the viral spike protein, preventing it from entering the patient’s cells and exacerbating the infection.

However, the virus has continually mutated as it works to correct ‘flaws’ that make it vulnerable to treatment. This has rendered previously authorized mAb treatments ineffective, with the FDA progressively revoking authorizations for these therapies as a result. For example, in November last year, the agency deauthorized bebtelovimab, the last of the COVID-19 treatment antibodies. And in January, a similar fate befell AstraZeneca PLC (NASDAQ: AZN)’s Evusheld, which was designed as a PrEP treatment (https://ibn.fm/OBKpX), and in the first nine months of 2022 generated $1.5 billion in sales, a testament to the huge demand for proactive COVID protection.

Although other non-monoclonal-antibody therapies remain authorized, none can be administered as PrEP for the prevention the COVID-19 disease, according to the FDA’s Emergency Use Authorization webpage (https://ibn.fm/41gyW). Furthermore, Pfizer Inc. (NYSE: PFE)’s Paxlovid, which is still effective against the new subvariants of the Omicron variant, has multiple contraindications for common drugs including blood thinners, heart medications, and prescribed statins. Those patients who were ineligible to receive Paxlovid would have previously received mAb-based drugs. But this is no longer the case.

“Encouragingly,” Amir Reichman, CEO of biotechnology company BiondVax Pharmaceuticals (NASDAQ: BVXV), wrote in his letter to shareholders published December 30, 2022 (https://ibn.fm/b62Lh), “our lead NanoAb candidate, currently being prepared for clinical trials, has demonstrated neutralization of all relevant Omicron subvariants.”

Reichman was highlighting one of the outstanding benefits of the company’s alpaca-derived nanosized antibodies (“NanoAbs”), which exhibit potential superior therapeutic capabilities for a wide range of diseases, including COVID-19. BiondVax, which focuses on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, has so far shown, through an ongoing in vivo preclinical proof-of-concept study, that its lead NanoAb candidate for the treatment of COVID-19 exhibits significant competitive advantages over existing mAbs and oral therapies.

According to statistically significant results released early January, BiondVax established that its inhaled therapy virtually eliminated the SARS-CoV-2 virus and prevented illness when administered prophylactically. The first set of results, announced January 6, showed that a group of COVID-19-infected hamsters that were treated with the company’s inhaled anti-COVID-19 therapy had over 30x lower lung viral titer on average than the placebo group. These results built on previously announced data, which indicated that the NanoAb treatment led to significantly milder illness and faster recovery compared to the placebo group (https://ibn.fm/MGKRe).

The second set of results, announced January 23, evidenced that when the NanoAb was administered by inhalation three hours before infection, it virtually prevented the hamsters from contracting the illness. In particular, the hamsters that received the inhaled NanoAb experienced no significant weight loss over the six-day trial, while the untreated control groups’ weight reduced by 12% on average (https://ibn.fm/WQZSQ). This data shows the prophylactic capabilities of the NanoAb, positioning the company to fill the huge void left by the withdrawal of Evusheld’s authorization.

BiondVax, which aims to replicate in human trials the efficacy demonstrated so far in its animal studies, believes there will continue to be a strong market demand for COVID prophylactics and treatments. This belief is supported by Pfizer’s recent report (https://ibn.fm/ffSCz), suggesting that revenues from COVID products is expected to grow in 2024. Backed by libraries with millions of COVID-19 NanoAb candidates developed by its collaborators at the Max Planck Institute for Multidisciplinary Sciences (“MPI”) and the University Medical Center Göttingen (“UMG”), BiondVax is well positioned to meet the demand.

“Indeed, the emergence of new variants remains a concern, and NanoAb therapeutics have the potential to quickly and effectively address new variants,” Reichman’s letter continues. “Our collaborators at MPI and UMG have generated libraries, each with ~300 million COVID-19 NanoAb candidates, as compared to mAb libraries that contain only thousands of options. Thus, as new variants emerge, we would expect to be in a position to rapidly develop a new neutralizing NanoAb”.

For more information, visit the company’s website at www.BiondVax.com.

NOTE TO INVESTORS: The latest news and updates relating to BVXV are available in the company’s newsroom at https://ibn.fm/BVXV

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

D-Wave Quantum Inc. (NYSE: QBTS) Highlights Commercial Customer Engagements and Cross-Platform Product Enhancements During Qubits 2023 Convention

 

• D-Wave’s Qubits annual user conference, currently in its seventh year, is one of the industry’s premier quantum computing events differentiated by its focus on real-world applications of quantum technology
• The company displayed its continued commercial customer momentum and real-time product innovation, reflecting the increasing enterprise adoption of quantum computing solutions
• The conference demonstrated how D-Wave’s proprietary technology helps organizations solve highly complex business problems today

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, announced new and renewed commercial customer engagements and product updates for its annealing and gate-model quantum computing solutions during the company’s annual Qubits 2023 user conference. The company’s continued commercial customer momentum and product innovation reflect the increased adoption of quantum computing solutions and showcase the technology’s ability to solve businesses’ most challenging computational problems today (https://ibn.fm/dRRdr).

The Qubits event, now in its seventh year, is one of the industry’s premier quantum computing events and is differentiated by its focus on the real-world application of quantum technology to today’s business problems. Quantum-hybrid applications on display at Qubits included solutions from: Mastercard (customer loyalty and rewards allocation), Davidson Technologies (missile defense optimization), Recruit Group (TV commercial allocation), Pattison Food Group (grocery operations optimization), SavantX (port operations optimization), and many more. In addition to showcasing commercial quantum applications during the conference, D-Wave announced that it had added several new high profile customers to its portfolio, working on a diverse set of potential use cases. New and renewing commercial customers working with D-Wave on quantum-hybrid use cases include Siemens Healthineers, Unisys, and Davidson Technologies. These companies are exploring various applications that span medical imaging, military defense optimization, and vehicle routing.

In the event keynote, Dr. Alan Baratz, CEO of D-Wave, outlined that practical quantum computing solutions are becoming essential to helping businesses compete, innovate, and grow. “As we gather at our annual Qubits user conference in Miami this week, the commercialization of quantum is on full display. Currently, more than 60 companies are working with us on real-world quantum-hybrid applications that are unlocking business value today,” Dr. Baratz underlined. “Unlike other modalities, annealing quantum computing is commercial-grade and enterprise-ready, and customers are realizing the benefits of this powerful technology now.”

During the conference, D-Wave shared the progress made toward its next-generation Advantage2TM annealing quantum computing system, expected to feature 7000+ qubits and 20-way connectivity, which will be implemented in a new lower-noise fabrication stack to enable customers to solve incrementally more complex problems with greater precision.

D-Wave also showcased several recent enhancements to its constrained quadratic model (“CQM”) hybrid solver in its Leap cloud service. These include continuous variables that enable better representation of constrained problems, the handling of weighted restraints that allow quantum developers to more easily and accurately model problems, and pre-solve techniques that reduce the size of problems and allow for larger models to be submitted to the hybrid solver.

Other milestones shared by D-Wave during the event covered the scalable qubit design and readout method validation and the company’s gate-model simulator launched in the Ocean suite of open-source tools. “Our relentless and on-time product delivery reflects a deep commitment to ongoing innovation that accelerates quantum computing adoption, usage and customer value,” Dr. Baratz added. “Through the continued development of our quantum annealing and gate model quantum solutions, we’re focused on building and delivering the full breadth of quantum solutions to our customers, both today and into the future, bringing our unique cross-platform vision to life.”

For more information, visit the company’s website at www.DWaveQuantum.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward-Looking Statements

This article contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which statements are based on beliefs and assumptions and on information currently available. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. We caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, which are subject to a number of risks. Forward-looking statements in this article include, but are not limited to, statements regarding the release and performance of the Advantage2 processor. We cannot assure you that the forward-looking statements in this article will prove to be accurate. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including general economic conditions and other risks; customer acceptance of our products and services; and the uncertainties and factors set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in the registration statement on Form S-1 filed by the Company with the SEC on February 13, 2023, as well as factors associated with companies, such as D-Wave, that are engaged in the business of quantum computing, including anticipated trends, growth rates, and challenges in those businesses and in the markets in which they operate; the outcome of any legal proceedings that may be instituted against us; risks related to the performance of our business and the timing of expected business or financial milestones; unanticipated technological or project development challenges, including with respect to the cost and or timing thereof; the performance of our products; the effects of competition on our business; the risk that we will need to raise additional capital to execute our business plan, which may not be available on acceptable terms or at all; the risk that we may never achieve or sustain profitability; the risk that we are unable to secure or protect our intellectual property; volatility in the price of our securities; the risk that our securities will not maintain the listing on the NYSE; changes in applicable laws and regulations; the effect of pandemics, geopolitical events, natural disasters, wars, or terrorist acts on our business or the economy in general; and the impact of inflation. Furthermore, if the forward-looking statements contained in this article prove to be inaccurate, the inaccuracy may be material. In addition, you are cautioned that past performance may not be indicative of future results. In light of the significant uncertainties in these forward-looking statements, you should not place undue reliance on these statements in making an investment decision or regard these statements as a representation or warranty by any person we will achieve our objectives and plans in any specified time frame, or at all. The forward-looking statements in this article represent our views as of the date of this article. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this article.

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Begins Trading on Toronto Stock Exchange

 Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) has obtained conditional approval to list its common shares on the Toronto Stock Exchange (“TSX”). According to the announcement, Eloro shares will trade under the trading symbol: ELO. The announcement also noted that the listing is subject to Eloro Resources fulfilling certain requirements of the TSX; those terms were outlined in a conditional approval letter that was dated Feb. 22, 2023. “This is a significant milestone for Eloro and its shareholders,” said Eloro Resources CEO Thomas Larsen in the press release. “The TSX is one of the world’s pre-eminent exchanges for mineral resource companies. A TSX listing will increase our visibility and profile in the capital markets and in the mining industry. Listing on the TSX will also offer benefits to shareholders such as enhanced market access for Canadian and international investors, increased access to capital and improved liquidity, as the company advances its flagship Iska Iska project in southern Bolivian.” 

To view the full press release, visit https://ibn.fm/HyCvm

About Eloro Resources Ltd.

Eloro is an exploration and mine-development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec. Through its Bolivian subsidiary, Eloro has an option to acquire a 100% interest in the highly prospective Iska Iska Property, which can be classified as a polymetallic epithermal-porphyry complex, a significant mineral deposit type in the Potosi Department in southern Bolivia. A recent NI 43-101 technical report on Iska Iska, which was completed by Micon International Limited, is available on Eloro’s website and under its filings on SEDAR. Iska Iska is a road-accessible, royalty-free property. Eloro also owns an 82% interest in the La Victoria Gold/Silver Project, located in the north-central mineral belt of Peru, some 50 kilometers south of Barrick’s Lagunas Norte Gold Mine and Pan American Silver’s La Arena Gold Mine.

NOTE TO INVESTORS: The latest news and updates relating to ELRRF are available in the company’s newsroom at https://ibn.fm/ELRRF

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php